These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 2821111)
1. A synthetic peptide homologous to the envelope proteins of retroviruses inhibits monocyte-mediated killing by inactivating interleukin 1. Kleinerman ES; Lachman LB; Knowles RD; Snyderman R; Cianciolo GJ J Immunol; 1987 Oct; 139(7):2329-37. PubMed ID: 2821111 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E. Harris DT; Cianciolo GJ; Snyderman R; Argov S; Koren HS J Immunol; 1987 Feb; 138(3):889-94. PubMed ID: 2433333 [TBL] [Abstract][Full Text] [Related]
3. Synthetic peptide corresponding to a conserved domain of the retroviral protein p15E blocks IL-1-mediated signal transduction. Gottlieb RA; Lennarz WJ; Knowles RD; Cianciolo GJ; Dinarello CA; Lachman LB; Kleinerman ES J Immunol; 1989 Jun; 142(12):4321-8. PubMed ID: 2524528 [TBL] [Abstract][Full Text] [Related]
5. Human IFN-gamma production is inhibited by a synthetic peptide homologous to retroviral envelope protein. Ogasawara M; Cianciolo GJ; Snyderman R; Mitani M; Good RA; Day NK J Immunol; 1988 Jul; 141(2):614-9. PubMed ID: 2968406 [TBL] [Abstract][Full Text] [Related]
6. Transcriptional down-regulation of tumor necrosis factor-alpha gene expression by a synthetic peptide homologous to retroviral envelope protein. Haraguchi S; Good RA; Cianciolo GJ; James-Yarish M; Day NK J Immunol; 1993 Sep; 151(5):2733-41. PubMed ID: 8360488 [TBL] [Abstract][Full Text] [Related]
7. The suppressive effect of a synthetic retroviral peptide on the human IFN gamma production is abrogated by the combined stimulation with IL-1 and IL-2. Ogasawara M; Cianciolo GJ; Mitani M; Kizaki T; Good RA; Day NK Cancer Detect Prev; 1991; 15(3):205-9. PubMed ID: 1905580 [TBL] [Abstract][Full Text] [Related]
8. Cytolysis of tumor necrosis factor (TNF)-resistant tumor targets. Differential cytotoxicity of monocytes activated by the interferons, IL-2, and TNF. Philip R J Immunol; 1988 Feb; 140(4):1345-9. PubMed ID: 2449501 [TBL] [Abstract][Full Text] [Related]
9. Suppression of lymphocyte proliferation by a retroviral p15E-derived hexapeptide. Oostendorp RA; Schaaper WM; Post J; Von Blomberg BM; Meloen RH; Scheper RJ Eur J Immunol; 1992 Jun; 22(6):1505-11. PubMed ID: 1534759 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein kinase C by a peptide conjugate homologous to a domain of the retroviral protein p15E. Gottlieb RA; Kleinerman ES; O'Brian CA; Tsujimoto S; Cianciolo GJ; Lennarz WJ J Immunol; 1990 Oct; 145(8):2566-70. PubMed ID: 2212653 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of murine cytotoxic T lymphocyte activity by a synthetic retroviral peptide and abrogation of this activity by IL. Ogasawara M; Haraguchi S; Cianciolo GJ; Mitani M; Good RA; Day NK J Immunol; 1990 Jul; 145(2):456-62. PubMed ID: 2195116 [TBL] [Abstract][Full Text] [Related]
12. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity. Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493 [TBL] [Abstract][Full Text] [Related]
13. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha. Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154 [TBL] [Abstract][Full Text] [Related]
14. Suppression of human interferon-gamma production by a 17 amino acid peptide homologous to the transmembrane envelope protein of retroviruses: evidence for a primary role played by monocytes. Haraguchi S; Liu WT; Cianciolo GJ; Good RA; Day NK Cell Immunol; 1992 May; 141(2):388-97. PubMed ID: 1576656 [TBL] [Abstract][Full Text] [Related]
15. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both. Ichinose Y; Bakouche O; Tsao JY; Fidler IJ J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Cianciolo GJ; Copeland TD; Oroszlan S; Snyderman R Science; 1985 Oct; 230(4724):453-5. PubMed ID: 2996136 [TBL] [Abstract][Full Text] [Related]
17. Rapid killing of actinomycin D-treated tumor cells by human monocytes. II. Cytotoxicity is independent of secretion of reactive oxygen intermediates and is suppressed by protease inhibitors. Colotta F; Bersani L; Lazzarin A; Poli G; Mantovani A J Immunol; 1985 May; 134(5):3524-31. PubMed ID: 4038989 [TBL] [Abstract][Full Text] [Related]
18. Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II. Ruegg CL; Monell CR; Strand M J Virol; 1989 Aug; 63(8):3250-6. PubMed ID: 2746730 [TBL] [Abstract][Full Text] [Related]
19. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde. Okubo A; Sone S; Tanaka M; Ogura T Cancer Res; 1989 Jan; 49(2):265-70. PubMed ID: 2463072 [TBL] [Abstract][Full Text] [Related]
20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage. Colotta F; Peri G; Villa A; Mantovani A J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]